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Acute Surgical 
Pulmonary Embolectomy:
A 9-Year Retrospective Analysis
Acute pulmonary embolism is a substantial cause of morbidity and death. Although the 
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines rec-
ommend surgical pulmonary embolectomy in patients with acute pulmonary embolism 
associated with hypotension, there are few reports of 30-day mortality rates.
We performed a retrospective review of acute pulmonary embolectomy procedures 
performed in 96 consecutive patients who had severe, globally hypokinetic right ventricu-
lar dysfunction as determined by transthoracic echocardiography. Data on patients who 
were treated from January 2003 through December 2011 were derived from health sys-
tem databases of the New York State Cardiac Surgery Reporting System and the Society 
of Thoracic Surgeons. The data represent procedures performed at 3 tertiary care facilities 
within a large health system operating in the New York City metropolitan area.
The overall 30-day mortality rate was 4.2%. Most patients (68 [73.9%]) were dis-
charged home or to rehabilitation facilities (23 [25%]). Hemodynamically stable patients 
with severe, globally hypokinetic right ventricular dysfunction had a 30-day mortality rate 
of 1.4%, with a postoperative mean length of stay of 9.1 days. Comparable findings for 
hemodynamically unstable patients were 12.5% and 13.4 days, respectively.
Acute pulmonary embolectomy can be a viable procedure for patients with severe, 
globally hypokinetic right ventricular dysfunction, with or without hemodynamic compro-
mise; however, caution is warranted. Our outcomes might be dependent upon institu-
tional capability, experience, surgical ability, and careful patient selection. (Tex Heart Inst 
J 2015;42(1):25-9)
A lthough pulmonary embolectomies have been attempted since Trendelen-burg f irst proposed their use in 1908, Steenburg and colleagues in 1958 were first to perform a successful traditional embolectomy in the United 
States.1,2 This procedure has been associated with excessive mortality rates, persistent 
right heart failure, intra-alveolar and interstitial pulmonary edema, and massive paren-
chymal and intrabronchial hemorrhage.1-3 It is not surprising, then, that the mainstay 
treatment in recent times has been nonsurgical therapy.
 Although most studies show historically high mortality rates (32% on the basis of 
pooled data from 30 studies and 1,047 patients from 1961 through 1984), recent in-
creases in the effectiveness of surgical techniques have resulted in lower mortality rates 
for pulmonary embolectomies.4,5 For example, a surgical approach described by Aklog 
and colleagues6 resulted in an 11% mortality rate among 29 patients, over a 3-year pe-
riod of study. All patients had anatomically extensive embolism and moderate-to-severe 
right ventricular (RV) dysfunction. Other investigators have shown similar results. For 
example, Lehnert and associates, in 33 patients who underwent embolectomy, achieved 
a 30-day mortality rate of 6% and a 12-year survival rate of 80%.7 Kadner and cowork-
ers also produced a low mortality rate of just 8% in 25 patients over a 7-year period.8 
Schoepf and colleagues’ study of patients with RV enlargement showed a 30-day mor-
tality rate of 15.6%, compared with 7.7% when RV enlargement was not present.9
 The American College of Chest Physicians Evidence-Based Clinical Practice Guide-
lines recommend surgical pulmonary embolectomy in patients with acute pulmonary 
embolism (PE) associated with hypotension, if 1) patients have contraindications to 
thrombolysis; 2) patients have undergone failure of thrombolysis or catheter-assisted 
embolectomy; or 3) patients are in a state of shock that is likely to result in death before 
thrombolysis can take effect; and 4) the surgeon possesses appropriate expertise, and 
obtainable or accessible resources are ready for use.10 Despite the above recommenda-
tion from the American College of Chest Physicians, surgical pulmonary embolectomy 
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in patients with acute PE associated with hypotension 
is still less frequently used than is thrombolytic therapy, 
and there are few reports of 30-day mortality rates.
 The purpose of this study is to describe our experi-
ence over a 9-year period with acute-PE patients who 
presented with severe (life-threatening), globally hypo-
kinetic RV dysfunction, as determined by transthoracic 
echocardiography (TTE). We herein provide prelimi-
nary descriptive analysis of early pulmonary embolec-
tomy in hemodynamically stable and unstable patients 
who presented with acute pulmonary embolus causative 
of RV compromise.
Patients and Methods
This study was conducted in compliance with the hu-
man-study guidelines of the authors’ institutions and in 
compliance with U.S. Food and Drug Administration 
guidelines. The protocol was approved by the institu-
tional review board (IRB #11-342B) and was granted a 
waiver of informed consent. We retrospectively studied 
the cases of 96 consecutive patients with acute, centrally 
located pulmonary embolus, and severe, globally hypo-
kinetic RV dysfunction who had undergone pulmonary 
embolectomy from January 2003 through December 
2011. This ref lected the experience of 3 tertiary care 
facilities within a large health system operating in the 
New York City metropolitan area. The experience of 
each surgeon performing surgical embolectomies at our 
institutions varies; of the 13 surgeons whose data were 
included, at least 8 had more than 15 years of experience. 
Catheter-based embolectomy is typically not performed 
at our institutions. Data were derived from health sys-
tem databases of the New York State Cardiac Surgery 
Reporting System and the Society of Thoracic Surgeons.
Outcome Variables
The major outcome variable was hospital death, defined 
as death within 30 days of the procedure or death dur-
ing the index hospitalization (beyond 30 days, if still 
hospitalized). Other outcome variables included post-
operative length of stay (LOS), discharge location, read-
mission status, and postoperative complications.
Diagnostic and Therapeutic Algorithm
All patients were evaluated for RV dysfunction, by 
means of TTE. Indications for surgery included severe, 
globally hypokinetic RV dysfunction on TTE, and 
computed-tomographic-angiography (CTA)–docu-
mented PE, with either a large clot burden in the main 
pulmonary arteries (PAs) or a saddle embolism. This is 
consistent with the 2014 definition of intermediate-risk 
PE.11
 No patients in this group had a history of chronic pul-
monary thromboembolic disease or evidence of chronic 
disease on CTA. All TTEs were completed by attending 
echocardiologists. The following measurements were 
typically taken: RV size in the 4-chamber view (RV 
enlargement was defined as a ratio of RV diameter to 
left ventricular diameter of >0.9), presence of tricuspid 
regurgitation, systolic PA pressure, tricuspid annular 
plane systolic excursion, and septal shift. In addition, 
patients with McConnell’s sign or abnormal right atrial 
size were evaluated.
 Most of the patients were transferred from outly-
ing hospitals or from other in-hospital services, with a 
completed diagnostic CTA scan of the chest accompa-
nied by intravenous administration of contrast material 
during the venous phase. For the few who were trans-
ferred without such a scan, one was obtained soon after 
transfer. Immediately after a CTA revealed main PA or 
saddle PA embolism, heparin therapy was initiated and 
a TTE was obtained to detect and evaluate RV strain 
or compromise.
 All patients who underwent pulmonary embolec-
tomy had either a saddle embolus or an obstructing 
left or right main PA embolus with severe, globally 
hypokinetic RV strain. All the patients who under-
went an embolectomy did so within one hour. Pulmo-
nary embolectomy was performed through a primary 
sternal splitting incision or partial upper sternotomy, 
with use of ascending aortic cardiopulmonary bypass 
(CPB) and either dual-stage venous CPB or separate 
superior and inferior caval cannulation. All were done 
in patients with a beating heart at normothermia. We 
also have routinely used pericardial carbon dioxide in-
sufflation to avoid pulmonary air entrapment and the 
release of endothelium-derived cytokines, which can 
contribute to “leaky” endothelium and noncardiogenic 
pulmonary edema.12-16 Our approach was to avoid isch-
emic injury to a stunned RV, keeping the right side 
of the heart unloaded and well-perfused, and avoid-
ing blind instrumentation of fragile PAs. A pulmonary 
arteriotomy and clot extraction was performed under 
direct vision with the use of gallstone forceps, sponge 
ring forceps, or both.
 On CPB with the right side of the heart decom-
pressed, the PA was double-looped with use of silastic 
vascular tape proximal to the bifurcation; then traction 
was applied. The PA was incised longitudinally from its 
confluence to just above the pulmonary valve (within 
1 to 2 cm of the valve). The clot was retrieved with 
use of a common duct basket forceps and suction tip. 
When all large fragments had been removed, the PAs 
were f lushed with saline solution and the pulmonary 
arteriotomy was closed with use of f ine Prolene suture. 
Temporary pacing wires and mediastinal drains were 
placed. The wound was closed in a normal fashion.
Statistical Analysis
Rates were computed by means of standard methods 
for estimating proportions and by applying exact 95% 
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confidence intervals. Otherwise, simple descriptive sta-
tistics were given. Comparisons of hemodynamically 
stable versus unstable patients were made by means of 
the Fisher exact test for categorical data and the Mann-
Whitney test for continuous data. A P value of less than 
0.05 was considered statistically significant. Data analy-
sis was conducted with the use of SAS software version 
9.2 (SAS Institute, Inc.; Cary, NC).
Results
Results for Entire Cohort
Our sample consisted of 96 patients. Seventy-two pa-
tients (75%) were stable (systolic blood pressure, >90 
mmHg), and 24 patients (25%) were unstable (systolic 
blood pressure, <90 mmHg) and therefore placed on 
vasopressors. For the 3 facilities in total, 43 patients 
(44.8%) had contraindications to tissue plasminogen 
activator (tPA). All patients had severe, globally hypo-
kinetic RV dysfunction on preoperative bedside TTE 
and almost all (93 patients [96.9%]) had severe RV en-
largement. The average grade of tricuspid regurgitation 
was 1.85/4 and the average estimated pulmonary systol-
ic pressure was 58.4 mmHg. All patients had saddle or 
bilateral main PA emboli on CTA and exhibited severe, 
globally hypokinetic RV strain and dysfunction, as de-
termined by TTE and as confirmed by transesophageal 
echocardiography in the operating room. One patient 
experienced, in transit, emboli in the RV cavity, and 5 
patients (5.2%) went on to surgery after having received 
tPA preoperatively, because they showed no improve-
ment in RV strain. Seven patients (7.2%) needed repeat 
intervention: 2 (2.1%) for recurring PE after inferior 
vena cava filter placement and 5 (5.2%) for symptom-
atic pericardial effusion.
 Sixty patients were male (62.5%) and 36 were female 
(37.5%) (Table I). The mean age at admission was 57.7 
± 14.5 years (median age, 59.3 yr); 53 (55.2%) were 
younger than 60 years of age. Seventy-two were white 
(75%) and 92 were non-Hispanic (95.8%). The total 
mean LOS was 11.7 ± 12.6 days (median, 8 d) (Table 
II). The postoperative mean LOS was 10.2 ± 12 days 
(median, 7 d). Although we cannot surmise that every 
patient with a LOS of 0 came to the emergency de-
partment, we determined on the basis of admission and 
surgery dates that 42 of these 96 patients (44%) had a 
LOS before surgery of 0 days. This is a conservative 
estimate of how many patients were referred from the 
emergency department or were transferred from another 
institution.
 The 30-day mortality rate was 4.2% (95% confi-
dence interval, 1.1%–10.3%); 4 of the 96 patients died 
(none in facility 1, 3 in facility 2, and 1 in facility 3). 
Sixty-eight patients were discharged home (73.9%) and 
23 to rehabilitation facilities (25%) (Table III). The 
total mean time on the ventilator, postoperatively, was 
32.9 ± 81 hours, and the total mean CPB time was 38.5 
± 23.8 minutes.
 Overall, there were few complications: 2 patients 
(2.9%) had a postoperative cardiac arrest, 7 (7.3%) had 
to undergo an unplanned cardiac reoperation or inter-
ventional procedure, 7 (7.3%) had respiratory failure as 
defined by mechanical ventilation time >48 hours, and 
3 (3.1%) experienced gastrointestinal bleeding. With 
regard to readmission, 8 patients (11.6%) were readmit-
ted; 4 (50%) of those readmissions were secondary to 
pericardial effusions and took the form of hemopericar-
dium—most likely caused by aggressive early oral anti-
coagulation or by systemic intravenous anticoagulation 
begun early in the perioperative period.
Comparison between Hemodynamically 
Stable and Unstable Patients
We def ine unstable patients as those requiring vaso-
pressors to compensate for systolic blood pressures of 
<90 mmHg. Given that unstable patients have usually 
had high morbidity and mortality rates, whether with 
surgery or with tPA administration, we looked specifi-
cally at outcomes among this high-risk population. As 
seen in Table II, hemodynamically stable patients had 
signif icantly lower postoperative and total lengths of 
stay (both P <0.001) than did unstable patients. Un-
TABLE I. Characteristics of the 96 Patients
          Variable Value
Male 60 (62.5)
Female 36  (37.5)
Age at admission (yr) 57.7 ± 14.5
 (median, 59.3)
   <60 53  (55.2) 
   60–70 22  (22.9) 
   71–80 18  (18.8) 
   81–90 3  (3.1)
Race 
   White 72  (75) 
   Black 24  (25)
Ethnicity 
   Non-Hispanic 92  (95.8) 
   Hispanic 4  (4.2)
Weight (kg) 99.2 ± 22.5
 (median, 100)
   45–68 7  (7.3) 
   69–90 26  (27.1) 
   ≥91 63  (65.6)
Height (cm) 173.1 ± 11.9
 (median, 175)
   <152 3  (3.1) 
   152–165 26  (27.1) 
   166–183 52  (54.2) 
   ≥184 15  (15.6)
 
Data are presented as mean ± SD or as number and percentage, 
unless otherwise stated.
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stable patients had signif icantly longer CPB time and 
postoperative total ventilator hours (both P=0.002) 
than did stable patients (Table III). There was a signif- 
icant relationship between the stability of patients and 
the discharge destination, with stable patients more 
likely to be discharged home (P=0.004).
TABLE III. Outcomes for All Patients and for Preoperatively Hemodynamically Stable versus Unstable Patients
 All Patients Stable Unstable  
     Variable N=96 n=72 n=24 P Value*
30-day death 4 (4.2) 1 (1.4) 3 (12.5) 0.047
Postoperative ventilation 32.9 ± 81 (11) 23.7 ± 50.4 (10) 71.8 ± 152.2 (26) 0.002 
   Mean ± SD (median), hr    
Cardiopulmonary bypass time 38.5 ± 23.8 (32) 35 ± 23.5 (29) 48.8 ± 21.8 (48) 0.002 
   Mean ± SD (median), min    
Discharge destination 
   Home 68 (73.9) 58 (81.7) 10 (47.6)  
   Rehabilitation 23 (25) 12 (16.9) 11 (52.4) 0.004 
   Other 1 (1.1) 1 (1.4) 0 
Complications 
   Postoperative cardiac arrest** 2 (2.9) 2 (3.6) 0  1.000 
   Unplanned cardiac reoperation 7 (7.3) 4 (5.6) 3 (12.5) 0.361 
     or interventional procedure 
   Respiratory failure 7 (7.3) 4 (5.6) 3 (12.5) 0.361 
   Gastrointestinal bleeding 3 (3.1) 0  3 (12.5) 0.014
Readmission status** 
   Readmitted 8 (11.6) 7 (13) 1 (6.7)  
   Not readmitted 57 (82.6) 46 (85.2) 11 (73.3) 0.046 
   Died 4 (5.8) 1 (1.9) 3 (20) 
 
*Hemodynamically stable versus unstable patients 
**Before 2007, data on some outcome variables were not routinely collected and were missing from the databases. The data were  
available for only 68 of the postoperative cardiac arrest variable, and for 69 of the readmission status variable of the total cohort of  
96 patients. 
 
Data are presented as mean ± SD or as number and percentage, unless otherwise stated. P <0.05 was considered statistically signifi-
cant.
TABLE II. Lengths of Stay for All Patients and for Hemodynamically Stable versus Unstable Patients
 All Patients Stable Unstable 
     Length of Stay (d) N=96 n=72 n=24 P Value*
Preoperative 1.5 ± 3 (1) 1.3 ± 2.5 (1) 2.4 ± 4 (1) 0.201 
Mean ± SD (median)
   ≤5 90  (93.8) 69 (95.8) 21 (87.5) — 
   6–10 3  (3.1) 2 (2.8) 1 (4.2) — 
   11–15 1  (1) 0  1 (4.2) — 
   16–20 2  (2.1) 1 (1.4) 1 (4.2) — 
   ≥21 0  0  0  —
Postoperative 10.2 ± 12 (7) 9.1 ± 12.8 (6) 13.4 ± 8.4 (10) <0.001 
Mean ± SD (median)
   ≤5 32 (33.3) 30 (41.7) 2 (8.3) — 
   6–10 40 (41.7) 29 (40.3) 11 (45.8) — 
   11–15 12 (12.5) 8 (11.1) 4 (16.7) — 
   16–20 4 (4.2) 1 (1.4) 3 (12.5) — 
   ≥21 8 (8.3) 4 (5.6) 4 (16.7) —
Total 11.7 ± 12.6 (8) 10.4 ± 13.4 (7) 15.8 ± 8.9 (14.5) <0.001 
Mean ± SD (median)
   ≤5 21 (21.9) 19 (26.4) 2 (8.3) — 
   6–10 42 (43.8) 35 (48.6) 7 (29.2) — 
   11–15 15 (15.6) 10 (13.9) 5 (20.8) — 
   16–20 8 (8.3) 4 (5.6) 4 (16.7) — 
   ≥21 10 (10.4) 4 (5.6) 6 (25) —
 
*Hemodynamically stable versus unstable patients 
 
Data are presented as mean ± SD or as number and percentage, unless otherwise stated. P <0.05 was considered statistically signifi-
cant.
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Discussion
Overall, our f indings suggest that pulmonary embo-
lectomy is a viable approach to consider as part of the 
treatment repertoire. Meyer and colleagues’ recent ran-
domized double-blinded study11 of fibrinolytic therapy 
in intermediate-risk PE patients who were evaluated by 
means of echocardiography or computed tomography 
found that although fibrinolysis prevents hemodynamic 
decompensation, it increases the risk of major hemor-
rhage and stroke. It is our hypothesis that patients with 
contraindications to thrombolytic use in this interme-
diate-risk group can benefit from surgical embolecto-
my. Our experience suggests that the appropriateness 
of surgery for acute PE revolves around 3 important 
principles: the significance of RV dysfunction on TTE 
or CTA, the presence of contraindications for throm-
bolytic therapy, and the safety of the surgical procedure 
being offered.
 As we say above, the American College of Chest Phy-
sicians Evidence-Based Clinical Practice Guidelines10 
recommend surgical pulmonary embolectomy in pa-
tients with acute PE that is associated with hypoten-
sion; however, this procedure is still not frequently used 
and there are few reports of the 30-day mortality rate.
 The results of our study support Aklog and colleagues’ 
previous findings that pulmonary embolectomy can be 
performed with low mortality rates.6 Schoepf and as-
sociates showed a 30-day mortality rate of 15.6% for 
patients with RV enlargement; patients without RV 
enlargement had a mortality rate of 7.7%.9 Our overall 
mortality rate of 4 (4.2%) is lower than those of previ-
ous studies, in which patients were treated with embo-
lectomy or thrombolytic agents.
Limitations of the Study
Our study is not without limitations. The retrospec-
tive design used in this study relies on the accuracy of 
written records, and missing or unavailable data could 
have  affected the results. In addition, there was no com-
parison group of medically treated patients. For these 
reasons, we cannot definitively state, on the basis of our 
evidence, that an early pulmonary embolectomy is a safe 
and effective procedure. It is also important to take into 
account the extent to which our results are dependent 
on the capability of our institutions, the extensive ex-
perience and ability of our surgeons, and careful patient 
selection.
Conclusion
Early pulmonary embolectomy in patients presenting 
with acute PE—manifested by severe, globally hypoki-
netic RV dysfunction, as determined initially by means 
of TTE—might be a viable alternative to thrombolytic 
therapy, but caution is warranted. We must continue, 
through large-scale studies, to identify factors that can 
influence the outcome of this potentially life-saving pro-
cedure.
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